PERSPECTA

News from every angle

Back to headlines

Commentary Criticizes Over-Evaluation of New Skin Cancer Therapy

A commentary criticizes the exaggerated assessment of a new combination therapy for skin cancer involving an mRNA vaccine, arguing that while the therapy is good for delaying tumor recurrence, calling it a 'big day for humanity' is counterproductive and harmful.

PostShare